http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-201892632-A1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EA-201892632-A1 |
| titleOfInvention | PHARMACEUTICAL COMPOSITION CONTAINING MEMANTINE AND MELATONIN COMBINATION |
| abstract | The invention relates to the chemical and pharmaceutical industry, namely to the pharmaceutical composition in the form of a tablet containing 2.0-15.0 wt.% Memantine; 1.5-10.0 wt.% Melatonin; 65.0-80.0% by weight of a filler selected from mannitol or a mixture of mannitol with copovidone; 4.0-15.0% by weight of disintegrant selected from crospovidone; 1.0-2.0 wt.% Binder selected from sorbitol; 1.0-2.5% by weight of a sweetener selected from maltitol, sodium saccharinate or a mixture thereof; 0.5-1.0% by weight of a lubricant selected from colloidal silicon dioxide, stearic acid, magnesium stearate, talc, or mixtures thereof; 1.5-3.0 wt.% Flavor, as well as the method of its production. The invention provides an expansion of the Arsenal of pharmaceutical compositions containing a combination of memantine and melatonin, as well as increasing its stability during storage and dissolution rate. |
| priorityDate | 2016-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.